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I. THE MECHANISM OF SHOCK ACCOMPANYING ACUTE MYOCARDIAL INFARCTION 
A. INTRODUCTION 
Shock is one of the most serious and controversial complications of acute 
myocardial infarction. The controversy has centered around the problem of 
whether the severe hypotensive state that may follow a myocardial infarct is 
truly shock in the same sense as hemorrhagic or traumatic shock, or whether 
it is a manifestation of congestive heart failure. Whatever the mechanism of 
its pabhogenesis may be, a shock-like state octurs in about 107. of all cases 
~--··- ioPI 
myocardial infarct•(l7,96). Untreate~ it carries a mortality rate of 807. or 
more (17,54), as compared with the over-all mortality in myocardial infarction 
of 20-307. (107). Its importance, however, is underscored by the fact that a shock 
state occurs in 40-457. of the fatal cases (57). Although a wide variety of 
therapeutic measures have been tried, few methods have successfully altered the 
mortality figures. 
Selzer (96) has stated that, "A rational therapeutic approach should be based 
on a knowledge of the physiologic disturbance to be corrected." Knowledge of 
the physiologic mechanism of this disorder has been impeded by confusion of its 
clinical picture with congestive heart failure, and by a relative lack of experi-
mental data. The clinical differendation between shock and congestive failure 
frequently is difficult, because the symptoms and signs of each are often over-
lapping. More precise hemodynamic measurements have been difficult to obtain 
because of the precarious state in which these patients are found, With the develop-
ment of simpler methods of obtaining hemodynamic measurements, more of·this in-
formation has become available, and has helped clarify the picture to some degree. 
l'l\ 
For many years, shock could not be produced by experimental coronary ligation; 
recently, however, a method of producing coronary shock has been devised, (7)
1 
and 
TABLE I 
SIGNS OF SHOCK AND HEART FAILURE COMPARED * 
Skin 
Sensorium 
Pulse 
Blood pressure 
Pulse Pressure 
Respirations 
Oliguria 
Circulation time 
Venous pressure 
(peripheral) 
Pulmonary edema 
Heart size 
Serous effusions 
Peripheral edema 
Venous pressure 
20/-
Marked liver enlargement 
Blood volume 
Shock 
---
! Cold, clammy, pale. 
Dull 
Rapid, feeble 
Low 
Decreased 
Increased 
Yes 
I Prolonged 
( Low, normal, increased. 
I 
I 
\ May be present 
I I Normal or decreased. 
! No 
1. 
I No I j Rare 
' 
. i 
' 1 Unusual 
' j Decreased 
Heart Failure 
Cold, clammy, slightly cya-
notic. 
Dull 
Rapid, feeble 
L01!7 
Decreased 
Dyspneic 
Yes 
Prolonged 
Normal or increased. 
I Usually marked. 
, Increased. 
I ~Yes 
1 Yes I 
1 Often 
l 
1 Yes 
j 
I i Increased 
I 
I 
I 
! 
--···~~--- . .J ... ···----··--·----·-·· 
* Agress, C.M. Management of Coronary Shock. A.M.J. Card. 1:231, 1958 
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has contributed a great deal to our knowledge of its pathogenesis. Thus, the 
therapeutic approach has gained firmer foundation, whereas it once was largely 
and 
empirical,' based on relatively unsupported theoretical considerations. Con-
versely, the greater success of some methods of treatment over others has pro-
vided further insight into the mechanism involved. 
B. CLINICAL FEATURES 
Shock must first be differentiated from the moderate hypotension which 
accompanies most cases of myocardial infarction and does not alter the prognosis. 
Herrick, in 1912, noted that a mild decrease in blood pressure is a constant 
feature of coronary thrombosis (58). In 1929, Levine commented on his general 
impression that the patients who fared best after coronary occlusion were those 
who had shown a marked fall in blood pressure, with only a slight subsequent rise 
(65). Many of his patients had suffered from angina prior to this attack; but 
with the sustained mild drop in blood pressure, their angina was often relieved. 
Therefore, mild post-infarction hypotension was regarded as having a protective 
effect on the damaged myocardium. On the other hand, Levine also noted that in 
fatal cases the blood pressure often fell quite rapidly, and was often unobtain-
able. 
Other studies, however, have placed more emphasis on the relationship between 
a marked fall in blood pressure and the gravity of the prognosis. In a series of 
1031 cases, Wright, Marple, and Beck (116) noted a prompt drop in blood pressure 
occurring in 93% of cases during the first week after the infarct, usually reach-
ing the lowest point within 24-72 hours. Occasionally the blood pressure did not 
reach a minimum reading for 7-10 days. The mean drop in systolic pressure during 
the first week was 51 mm Hg., and was greater among patients who died, (66 mm. Hg.) 
than among those who survived, (48 mm. Hg.). A similar pattern was observed for 
ancl alth ... ,~-. 1h• ........... il1di4stoJ;c pr•u~--
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was a greater correlation between the diastolic fall and the gravity of the prog-
nosis. No distinction was made between prvviously normotensive and previously 
hypertensive patients in this data, but generally a greater fall in blood pressure 
is noted in previously hypertensive patients. 
Others have noted that the magnitude of the fall in pressure in relation to 
the previous level may 
1 \?.C.:·).-' f 
be correlated with ~. ~~yertty of the prognosis in hyper-
tensives, but not in normotensives (86). In these patients, there appears to 
be a critical level, below which the increased mortality associated with shock, 
occurs. In most series, a systolic pressure of 80 mm. Hg. sustained for several 
hours has been associated with a !IUtinctl'y bad prognosis (6,19). 
The pulse pressure has also been cited as an important prognostic sign. 
Master (69) observed that the pulse pressure was of prognostic significance only 
if under 20 mm. Hg., although one patient in his series survived with a pulse 
pressure of tess than 10 mm. Hg. Mintz and Katz (75) stated that a pulse pressure 
below 25 mm. Hg. implied a mortality rate of 50%, &s compared with the over-all 
mortality of 22% in their series. The narrow pulse pressure in shock due to 
myocardial infarction may expain some of the reports of an unobtainable or 0/0 
-,___ . --, ~'\ 
auscultation .of ~~he pulse 'depends on pulse blood pressure (23), because the 
pressure. 
~-~~-,-:r·:r·-~'::-~_~;/.'/'.~: ... ::·(, ~; [ v-'+·· tt.,:·.t-;~.-~ --
The blood pressure, however, is by no means an absolute indicator of the 
presence or severity of a shock state. Cases have been reported in which the 
systolic pressure was less than 70 mm. Hg. yet the patients were not in shock 
based on symptomatic criteria (40). Hypertensives, on the other hand, may be in 
shock with blood pressures in the range of normal (69). 
Although shock has been defined in many ways, aost agree that it is present 
l7t) 
when blood flow to peripheral tissues is curtailed, and that it is manifested 
• 
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~ clinically by the compensatory adjustments tending to channel the flow of blood 
to essential organs. The fall in blood pressure in shock is accompanied by a 
compensatory vasoconstriction which appears earliest in skin, skeletal muscles, 
and kidneys (117), and is thought to be sustained by stimulation from chemo-
receptors and baroreceptors (10). R~gienal differences in extent and degree of 
vasoconstri~tion are accounted for by differences in s~pathetic innervation 
and patterns of vascular distribution (117). The dominant clinical signs and 
symptoms, reflecting the underlying disorder and the compensatory adjustments 
are those of weakness, pallor, cold skin with excessive sweating, usually mental 
clouding, and diminished urine output. Frequently, the characteristic pain of 
myocardial infarction is absent, and perhaps is obscured by the weakness and 
mental clouding. The picture can vary from that of sudden syncope (26) and 
death, to the gradual progression of symptoms of weakness, dizziness and nausea. 
Also, the onset may be characterized by severe pain followed by callapse. 
The variability of the clinical picture has created a problem in the eval-
uation of therapeutic measures. For this purpose, Agress and his group (6) have 
established certain criteria for defining shock accompanying myocardial infarction 
as a clinical entity. These include: (1) marked hypotension, specifically a 
fall in systolic blood pressure to 80 mm. Hg or less, (2) confirmatory clinical 
signs, such as anuria or severe oliguria, pallor, cold sweaty skin, and dulled 
sensorium, (3) autopsy or EKG evidence of acute myocardial infarction, (4) absence 
of other potential causes of shock. Generally the urinary output is the most 
accuratev· means of differentiating shock from simple hypotension, whereas mental 
changes are the least accurate. These criteria reflect the pattern of vasoconst-
riction. Although the brain is extremely sensitive to the effects of sudden 
diminution of its vascular supply~~),the kidney is more consistently affected in 
shock, because blood is supplied to the brain at the kidney's expense. 
-s-
In fulfilling the last of Agress' criteria, it is necessary to differentiate 
between shock following myocardial infarction, and hypotensive states which can 
precipitate an acute ischemic injury to the myocardium. These states include acute 
hemorrhage, trauma, dehydration, cerebral thrombosis or hemorrhage, and pulmonary 
embolization.(87). Shock following an infarct may also be due to other complicat-
ions such as myocardial rupture and tamponade, cerebral embolism, arrhythmias, 
infection, or the rapid intravenous administration of analgesic drugs. Other 
clinical conditions which may simulate shock due to myocardial infarction are 
acute pericarditis (17), myocarditis, pedunculated myxoma or ball-valve thrombus 
in the heart, dissecting aortic aneurysm, and acute congestive heart failure (87). 
C. CLINICAL HEMODYNAMIC STUDIES 
Within the bounds set by these criteria, there has been room for much d<~_bate 
as to whether the condition under discussion actually is shock. Wiggers (114) has 
argued that the use of the term shock depends upon the basis on which the diagnosis 
is made; that is, whether one would define shock in terms of wh~cn clinical signs 
and symptoms appear, or in terms of wHCh part of the cardiovascular system is 
primarily affected. Admitting the existence of the similarity between the clinical 
syndromes following acute coronary occlusion and the acute loss of blood or plasma 
Wiggers attributes it to the fact that the cardiac output is diminished in both 
conditions, but for different reasons. The same compensatory mechanisms, therefore, 
are set in operation regardless of whether the reduced systolic discharge is 
primarily due to a defective venous return, as in hemorrhage, or to depression of 
the total contractile capacity of the ventricles, as in acmte myocardial infarction. 
Thus on the basis of a low blood pressure, small pulse, feeble rapid heart action, 
cold, pale and clammy skin, one can include the circulatory failure of coronary 
occlusion in the category of clinical shock. Wiggers, however, would exclude it 
-6-
~ from this classification because he believed that it is not initiated by a reduct-
ion in effective circulatory volume and venous return, and that death does not 
ordinarily occur as a result of an irreversible state in the peripheral vessels. 
This differentiation, furthermore,has been insisted upon for therapeutic reasons, 
principally that in one condition transfusion may improve the circulation, but in 
the other it would only embarass the heart. 
Wiggers' argument is characteristic of the general problem of whether shock 
accompanying myocardial infarction can be attributed merely to a central defect 
in myocardial function, or whether it can be associated with a peripheral mechan-
ism. Wiggers assumed that the lack of an increased venous pressure disqualified 
this condition from the definition of< shock. Nevertheless, clinical observations 
have revealed that venous pressure may be either increased or decreased; (36); 
these findings have lent support to the concept of a peripheral mechanism. Boyer (20) 
however, has stated that increased venous pressure need not accompany decompen-
sation of the left ventricle, becawse the blood volume can be redistributed on 
the venous side, filling the reservoir of unused venous channels without increas-
ing the venous pressure. As evidence for this concept, he refers to the fact 
that large amounts of fluids can be transfused into normal humans without a remark-
able increase in venous pressure. This capacity, however, largely depends on the 
state of the blood volume at the time. Thus a myocardial infarction in a previous-
ly decompensated patient with an expanded blood volume, is likely to result in 
shock accompanied by an increated venous pressure. In a previously well patient, 
the presence or absence of shock still depends only on ~he quality and quantity 
of uninfarcted left ventricle. If the cardiac output falls, blood is dammed back 
on the venous side, filling the venous reservoir. As a result the arterial 
pressure drops, and the veno~ pressure remains normal or low • On this basis, 
-7-
Boyer regards an inadequate cardiac output as the primary factor in shock of 
myocardial origin, regardless of the presence or absence of signs of congestive 
failure. 
Subsequent clinical and experimental studies clarified many of these con-
cepts and brought in many new considerations. An early study by Fishberg, 
Hitzig, and King (37) presented evidence indicating that shock associated with 
acute myocardial infarction is similar to other varieties of shock in that it 
is characterized by lowered venous pressure, marked decrease in venous return, 
and diminished circulating volume. In their series, such cases occurred more 
frequently in the group of patients suffering from a first coronary attack, 
than in the group suffering second or later attacks. Many of the patients with 
a history of previous infarction or arteriosclerotic heart •isease presented a 
clinical picture of myocardial infarction dominated by congestive heart failure, 
with increased venous pressure, blood volume, and circulation time. Nevertheless, 
in approximately one-fourth of the cases classified as chronic heart disease, the 
venous pressure was low, and the clinical picture was characteristic of shock 
rather than congestive failure. The authors concluded that two mechanisms, 
decreased cardiac output'arld neurogenic peripheral circulatory failure, were 
operating to depress the blood pressure. However, they stated that the peripheral 
factor was the more important of the two because of the diminished circulating 
volume and venous pressure. 
The opposite point of view was supported by Stead and Ebert (105), who 
compared four patients in terminal decompensated congestive failure, with six 
cases of shock secondary to myocardial infarction, proven by EKG or autopsy. 
Both groups presented essentially the same clinical pictures. There was pallor, 
cyan6sis, sweating, dyspnea and other evidence of pulmonary edema in each case. 
The patients in terminal congestive failure had markedl~levated venous pressures, 
whereas in the post-myocardial infarction group the venous pressur~s were slight-
ly elevated or normal. Both had diminished blood pressures with narrowing of the 
pulse pressure. According to these authors, both groups represent decompensation 
of the heart along the downward limb of Starling's curve, bringing about dimin-
ution of cardiac output, and signs of peripheral circulatory insufficiency. When 
decompensation occurs after an acute insult to a portion of the myocardium, signs 
of peripheral circulatory collapse are more likely to occur, because time has 
not allowed for a compensatory expansion of the blood volume. The venous return 
in this situation is shown to be entirely adequate by the normal or slightly 
increased venous pressure even in the more typical cases of shock. As further 
proof, 500 cc or more of blood was removed from each of two patients in shock, 
with no apparent ill effedt. It was therefore concluded that peripheral circula-
tory failure following acute myocardial infarction primarily reflects a diminish-
ed cardiac output in the face of an adequate venous return. This, they believed, 
more closely fits the definition of congestive failure than that of shock. 
Each of these two papers illustrates the type of evidence used on either 
side of the controversy concerning what is the mechanism of coronary shock, and 
what is the proper approach to treatment. Both can be criticized on the basis of 
the small number of observations in each group, which has obviously prejudiced 
the conclusions. All of thepatients with the appearance of peripheral circulatory 
collapse following myocardial infarction in Stead's series correspond to Fishberg's 
group with myocardial infarction superimposed on previous heart disease, as all 
of them had previous angina pectoris. The presence of pulmonary edema and an 
elevated venous pressure indicate some degree of cardiac decompensation,. but do 
not exclude peripheral circulatory collapse. Furthermore, pulmonary edema and 
increased venous pressure may occur ~n response to hypotension alone, without any 
cardiac involvement (29,50). Similarly, Fishberg's group of patients with dimin-
-9-
ished venous pressure suggests some form of circulatory collapse, but does not 
exclude the role of the damaged myocardium in decreasing the cardiac output. 
The persistence of some relative hypotension in patients who survive has been 
regarded as evidence that the damage to the myocardium plays a direct role in 
diminishing the blood pressure. 
Other observers attempted to evaluate the comparison between this and other 
forms of shock by the determination of the blood volume. Although Fishberg and 
his associates reported the blood volume to be diminished, their data has been 
ctiticized for having only one case with an unequivocally subnormal blood volume, 
(55)1 and for the use of the Congo Red method which may have introduced a large 
error because of its diffusability (1). Stead and Ebert, using the Evans Blue 
technique, also reported a slight decrease in plasma volume in some of their 
cases. However, the presence of pulmonary edema may have accounted for these 
findings, and is consistent with the reported increase in hematocrit. Agress 
et al. (1), clarified the situation with blood volume dete~inations on 32 patients 
with clear-cut evidence of acute myocardial infarction, classified as having no 
shock, mild shock, and severe shock. The severe shock group fitted the criteria 
of a blood pressure less than 80 mm. Hg and had definite clinical signs of 
circulatory collapse. Cases in which shock was not present showed no deviation 
from the expected blood volume, whereas in both mild and severe shock, drops of 
approximately 16% were observed. It should be noted that Wiggers has found a 
30-40% decrease in blood volume necessary for the production of hypovolemic shock{113~ 
The only significant difference between the mild and severe groups was the 
relation of the change in blood volume to the time elapsed after the onset of 
the infarct. Cases of mild shock characteristically showed an initially low 
blood volume, rising with time to normal or elevated levels. All of these patients 
-10-
subsequently recoverd. The severe shock group showed an initial depression of 
A 
blood volume, followed by a subsequent progressive decline. There was relative-
ly greater contraction of plasma volume in both groups, but there was no evidence 
of a relative difference in hemoconcentration between the two groups. Plasma 
losses therefore could not be attributed to factors such as pulmonary edema, which 
was aore prominent in the severe group. 
On the basis of these blood volume determinations, Agress commented on the 
unreliability of using the venous pressure as a means of differentiating con-
gestive heart failure from shock. In his opinion, because congestive heart failure 
may complicate shock following myocardial infarction, the effect of shock in re-
ducing the blood volume may be made inapparent. Thus the concept that the venous 
pressure is low in shock and high in congestive failure may be inappropriate in 
studying this type of patient. Agress found that venous pressur~were frequently 
elevated in severely shocked patients even with diminished blood volumes, and 
attributed this increase to extreme venoconstrictio~ccur~ng in shock. This 
A 
observation stands in sharp contrast to Boyer's concept of venous pooling in 
shock. 
Attempts to evaluate more com~tely the hemodynamics of the shock state 
following acute myocardial infarction have been handicapped by the difficulties 
of imposing additional procedures upon seriously ill patients. The development 
of the Hamilton dye technique for estimating cardiac output has greatly simplified 
an important aspect of the problem (38). Nevertheless, the population in each 
of these studies has been quite small, and therefore difficult to evaluate. 
Fries et al (38), in 1952, carried out hemodynamic studies on 11 patients ~h 
acute myocardial infarction,, and obtained control values from 7 normal medical 
students, and 5 hypertensive patients. The patients with acute coronary disease 
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were classified as mild, severe, and as cardiogenic shock. The latter group 
consisted of 4 patients, and was chosen principally on the basis of a clinical 
appearance of shock. Thar average mean blood pressure was 79! 11 mm. Hg. The 
blood volumes and venous pressure of the severe cases were elevated over the 
controls, but there were no significant differences between the severe cases 
with shock, and those without shock. Although the cases classified as severe 
showed a depression of cardiac output and stroke volume, the lowest values were 
found among the patients in shock. The str.ke volume was particularly depressed. 
+----The most notable finding, however, was that the total peripheral resistence 
of the shock cases was significantly high~r than that of the severe cases 
without shock. It was, iryfact, higher than the peripheral resistence of the 
hypertensives in the series. 
This data was regarded as clear evidence that peripheral circulatory failure 
is not a cause of shock following acute myocardial infarction. Fries suggests 
a sequence of events in which a severe infarct, or the infarction of a previous-
ly damaged ventricle, diminishes myocardial contractility, producing a drop in 
stroke volume and a subsequent fall in blood pressure. Reflex factors tend to 
cause an increase in total peripheral resistance and tachycardia. The sequence 
is similar to that occurring in hypovolemic shock, although in this instance 
the initiating factor is the loss of myocardial contractility. However, in 
shock of myocardial 6rigin, the compensatory mechanisms may be of only temporary 
benefit to the organism. Fries concluded that peripheral vasoconstriction, 
particularly venoconstriction, tachycardia, and fluid retention secondary to 
diminished renal blood flow, all tend to increase the load on the damaged heart 
and throw the patient into congestive heart failure. 
In a later hemodynamic study, Smith, Wilker, and Fox (103) found that the 
cardiac indeB tended to be lowest in patients with acute myocardial infarction 
-12-
and shock, but that other patients with aaate myocardial infarction had equally 
low cardiac indices, and no evidence of shock. These patients were not in 
congestive failure, nor was any cardiac dysrhythmia present to explain the low 
cardiac index. The total peripheral resistance was elevated in four of the 
shocked patients, but was normal in three others. Moreover, two of the patients 
with myocardial infarction without shock had elevated peripheral resistances. 
Smith's values for venous pressure and plasma volume agreed largely with those 
of Fries. Nevertheless, the variations in the pattern of cardiac output and 
peripheral resistance cast some doubt on the previous author's characterization 
of the syddrome. Similar variability in cardiac output and peripheral resist-
ance among coronary patients with and without shock was also observed in a later 
study by Gammil (40), and in another by Gilbert et al (45). In the latter sttudy, 
total peripheral resistance tended to be elevated in the shock group, except in 
one instance, in which the blood pressure was the lowest of the group. In each 
of these studies the sample is too small to derive a valid statistical conclusion. 
It is evident, however, that at least some cases of shock of myocardial origin 
may involve peripheral decompensation, or at least a failure of the total peri-
pheral resistance to rise in the face of a falling cardiac output. 
D. EXPERIMENTAL STUDIES 
Binder reviewed a wide range of mehhods, of experimentally injuring the 
myocardium, none of which were capable of producing shock (17). The method of 
coronary artery ligation has been used widely, and according to Binder, has 
been associated with only a mild drop in blood pressure, ventricular fibrillation, 
or heart failure. Fishberg, (37), however, cites the work of Condorelli in the 
German literature, who suggested that more than the diminished force of myocard-
ial contraction was responsible for the hypotension following coronary occlusion. 
Condorelli found that occlusion of the left coronary artery of a dog was follow-
ed by a considerable decrease in aortic pressure, which rose as soon as the clamp 
was released. If the vagi and sympathetic& to the heart were bilaterally section-
ed, however, subsequent occlusion produced no decrease in aortic pressure until 
ventricular fibrillation set in. 
Gross, Meadlowitz, and Schauer (55,72,73) reported a series of experiments 
in which they demonstrated a diminished cardiac output following ligation of the 
left anterior descending coronary artery in both the open chest and closed chest 
dog. The cyanide circulation time was prolonged, but blood volume and arterial 
and venous pressures were not significantly altered, The maintenance of blood 
pressure in face of diminished cardiac output was attributed to compensatory 
vasoconstriction. However, attempts to deenervate the heart by bilateral vagotomy, 
sympathectomy, and cutting the aortic depressor nerves, leaving the nerves from 
the carotid sinus intact, caused a greater fall in blood pressure following 
coronary ligation than had been observed previously. This was thought to be 
the result of the interruption of some of the pathways for compensatory vaso-
constriction, Nevertheless, since the measured decrease in cardiac output was 
still of greater magnitude than the hypotension, the diminished cardiac output 
was thought to result from ischemia of the myocardium directly, and not reflex 
factors, or diminished venous return. 
In 1951, Agress and his group reported that they had successfully produced 
shock following e~perimental myocardial infarction by the injection of plastic 
microspheres directly into the coronary circulation (2). The spheres were deposit-
ed via a catheter passed through the left carotid artery into the aorta above 
the sinus of Morgagni. Initially the chest had to be opened to occlude the aorta 
while the beads were injected. The object of this procedure at first was to 
-14-
verify Agress' previous finding of a diminished blood volume in clinical shock 
of myocardial origin. A corrected deficit of 20% was attributed to the shock 
state, but significant congestion was not found in any of the organs of these 
animals, including the lungs, as compared to controls. The mechanism therefore, 
was undetermined. In subsequent experiments, however, the technique was refined 
so that the aorta was occluded by means of a balloon attached to the catheter, 
so that the chest need not be opened (3). The presence •f coronary shock was 
determined by the following criteria: (1) reduction of mean arterial pressure by 
30%, (2) maintenance of this reduction with no upward trend for at least 30 minutes, 
(3) EKG evidence of severe myocardial injury, (4) absence of arltthmias. 
"' 
It was found that myocardial injury could be produced with embolization of 
spheres of varying size, but that only optimal sized spheres would produce a 
state of shock (60). Spheres of 3251" did produce shock, whereas spheres of 190 I" 
and 450 ("did not. Injection studies revealed that the 350 I" spheres tended to 
lodge at the bifurcations of the right angle branches of the main coronary 
arteries (see figure), having an average caliber of 290~ regardless of the weight 
of the dog. The 450 I' particles would not enter these branches, whereas 190 f'l 
particles passed through to more distal branches. The size of the ischemic area 
produced by each embolus was roughly proportional to the size of the occluded 
vessel, but the incidence of shock was not related to the size of the infarct. 
The mortality rate was high'.in d6gs with large infarcts, however, but diminish-
ed blood pressure did not play a role. The authors concluded that specific nerve 
endings in the walls of the right angle vessels of the dog myocardium may orig-
inate a reflex which inhibits compensatory mechanisms responsible for maintain-
ing the blood pressure, following a decrease in cardiac output. 
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Using this technique, hemodynamic measurements were made in a series 
of dogs following coronary artery embolization. The data obtained in nine 
dogs which remained normotensive were compared with those obtained in 12 
dogs in which severe hypotension was produced (5). The amount of myocardial 
injury and the reduction in cardiac output and stroke volume were approx-
imately equal in the two groups. The pulse rate tended to rise in the normo-
tensive group, whereas bradycardia was prevalent amohg the hypotensives. The 
most significant difference, however, was to be found in the total peripheral 
resistance, which rose markedly (I 78%) in the normotensives and failed to 
rise above I 1% in the shocked animals. The central venous pressure was found 
to rise with both types of injury, but while the onset of hypotension was 
rapid, the rise in venous pressure did not take place within the first hour. 
This was suggested as additional evidence that shock was not the result of 
heart failure. 
Bilateral vagotomy was performed in twu additional animals to eliminate 
c. 
the Jarish-Bezold reflex. This procedure did not prevent the hypotensive state 
1\ 
following coronary embolization, but did eliminate the bradycardia. In two 
injured hypotensive animals, cardiac output measurements and total peripheral 
resistance values were obtained before and after infusion of levarterenol. In 
both animals, cardiac output, total peripheral resistance, and mean arterial 
pressure were significantly elevated above pre-levarterenol levels, showing 
that the shocked animal is able to elevate its total peripheral resistance as 
well as its cardiac output. Thus it is unlikely that a maximal degree of 
vasoconstriction was present in the shocked dog. On the other hand, certain 
animals were found to be more susceptible to profound hypotension than others, 
and these animals tended to have lower cardiac outputs, and hightr ~otal peri-
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pheral resistance initially. 
In face of these observations, the authors concluded that the hypotension 
could not be the result of myocardial injury alone, and that some extracardiac 
mechanism, either reflex, humoral or both, must exist. The rapidity with which 
the shock occurred, in their opinion, suggested a reflex arising from the injur-
ed area, which in some way interferes with the normal homeostatic mechanism, 
and prevents the usual rise in total peripheral resistance. However, the cardiac 
injury, was admittedly severe, and the role of the diminished cardiac output in 
lowering the blood pressure, must be considered the primary factor in shock. 
In no instance did peripheral vascular collapse occur. Rather, collapse occur-
red only in the sense of failure of compensation for the drop in cardiac output. 
E. PERPETUATING FACTORS 
According to Wiggers definition, a progressive course leading to a state of 
irreversibility is an essential part of the shock syndrome. Most therapeutic 
studies of shock following myocardial infarction have emphasized that early 
treatment is perhaps the most important factor leading to any improvement in 
• 
the mortality figures (19,50), and that contrary to Wiggers' opinion about shock 
of myocardial origin, after a certain period of time irreversibility does dlvelop 
(88). Irreversibility implies a state in which the blood pressure may be support-
ed by transfusions or vasopressor agents, but the body never regains the capacity 
to maintain the blood pressure independently. The factors which lead to irrevers-
ibility are not usually related directly to the faccors which initiated the hypo-
tensive state, but are attributed to secondary or perpetuating factors which arise 
as a result of the hypotensive state itself. Originally, the irreversible stage 
of hemorrhagic shock was assumed to be caused by increased capillary permi~ability 
secondary to anoxia, whichfaad to progressive loss of fluid from the circulation (113). 
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Recently there has been a great deal of experimental work in this area, and 
many more perpetuating factors have been suggested. 
Some of the proposed mechanisms of irreversibility include the release of 
a vasodepressor material by the liver, the absorbtion of bacterial toxins from 
the gut, the development of adrenal insufficiency, and myocardial depression 
secondary to diminished coronary perfusion pressure. Although this last factor 
is highly significant in shock following myocardial infarction because 6f its 
relationship to the initiating event, molt of the mechanisms of irreversibility 
are related to peripheral vascular decompensation. Attempts to reverse any 
of these mechanisms have met with little success clinically, and the chief 
therapeutic implication of these studies thus far has been that shock must be 
treated early. 
The autopsy findings of Blumgart, Schle~)(inger, and Zoll (18) provided 
dramatic evidence of the deleterious effect of shock upon the myocardium. They 
demonstrated the presence of multiple fresh thromboses in several patients who 
died in shock. Shock was attributed to several causes, but in three cases it 
was secnridary to acute myocardial infarction. They believed that the shock state 
resulted in impaired nutrition to the coronary arteries themselves, causing 
rupture of intimal capillaries and hemorrhage into pre-existing atheromas. When 
shock occurs following coronary occlusion, these effects might be presumed to 
be most harmful because of the presupposed atherosclerotic process. 
Corday et al (27), demonstrated experimentally the effects of shock on the 
damaged myocardium. The left anterior descending arteries were ligated in a 
group of dogs, and hemorrhagic shock was superimposed in half of them. 
~At this time, experimental shock secondary to myocardial infarction alone 
had not been produced. The hypotensive animals were found to have diminished 
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collateral blood supply to the ischemic area, and diminished perfusion of the 
non-ischemic areas of myocardium. After ligation, the ischemic area was ob-
served to lose contractility and balloon during systole. In the presence of 
shock, the ballooning became more extensive as were the EKG changes, and a 
general improvement was noted after reinfusion of heparinized blood. Measurements 
of myocardial contractility in normotensive dogs with partial coronary occlusion 
were normal, whereas in hypotensive dogs, contractility was decreased. Thus 
in the presence of hypotension the remaining myocardium is prevented from 
effectively compensating for the non-contractile, infarcted area. These re-
sults effectively contradict previous statements that hypotension was not harm-
ful in coronary insufficiency because the requirements for cardiac work was 
reduced. 
In studying a series of battle casualties for evidence of systemic pathology 
consequent to shock, T.B. Mallory (67) found that no consistent changes were 
found in cases dying within 4,8, or 12 hours after the onset of shock, but that 
cases surviving fer 18 hours or more consistently showed fat vacuolization in 
the parenchymal cells of the heart, liver, and kidney. Melcher and Wolcott also 
demonstrated similar changes in myocardium following various techniques of 
experimental shock (71). Although these findings are evidence of tissue damage 
in these organs consequent to shock, extensive changes such as these are notlike-
ly to be associated with the development of irreversibility, because the necessary 
timec;lag does not correlate with the more rapid development of irreversibility 
in severe shock, usually within four hours. The causitive changes, if they 
occur in these organs, must operate on a submicroscopic biochemical level. 
Shorr, Zweifach, and Chambers (98) observed that the irreversible state follow-
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ing prolonged hypotension was characterized by decreased spontaneous vaso-
constriction, and diminished reactivity to tepically applied epinephrine in 
terminal arteriola:· and precapillaries, of the rat mesoappendix. This they 
believed was responsible for increased filling of the capillary bed, and dim-
inished venous return in irreversible shock. Furthermore, their suspicion 
of a humoral factor producing these changes was confirmed by the ability to 
induce similar changes in the meso-appendix of normal rats, bp the trans-
fusion of blood from severely shocked animals. These investigators attributed 
the initial intensification of vasomotion during impending shock, and the sub-
sequent reversal of this effect, to two vasotropic factors designated VEM, and 
VDM. Briefly, both VEM and VDM are products of anaerobic metabolism, produced 
primarily in kidney and liver, respectively. VDM is also formed in skeletal 
muscles and spleen, but at slower rate than in liver. Also, the blood flow to 
the spleen is markedly curtailed during hypotension. Normally, the liver is 
capable of inactivating VDM, but loses this capacity under anaerobic conditions. 
The VEM principle has not been isolated as yet, but is known to be separate 
,.;: r1~' t/l '' from angiot:aillll6a. VDM activity', however, has been found to be related to a 
single subst~e, ferritin. 
Fritz and Levine (39) utilized the Chambers -~eifach rat mesoappendix 
preparation to 
responsiveness. 
determine the role of adrenal corticoid depletion on vascular 
They found that the vasoconstriction response~~pical nor-
,1 
epinephrine was diminished during stress in the adeenalectomized rat, but that 
reactivity was completely restored by local application of adrenal cortical 
extract. They concluded that adrenal cortical steroids are required for the 
response of small vess~ to physiological vasoconstriction, and that priming 
might be prerequisite to a pharmacologic vasoconstriction. Previously this' 
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group had demonstrated that the inability to maintain blood pressure was res-
ponsible for the increased susceptibility of adrenalectomized dogs to fatigue 
and other stresses (83). They subsequently demonstrated that adrenalectomized 
dogs show an initially diminished pressor response to norepinephrine adminis-
tration as compared to normal controls (84). The pressor response of the 
adrenalectomized animal could not be maintained and progressively fell to shock 
levels despite administration of large quantities of norepinephrine. 
~ Single injections of adrenal cortical extract potentiated the blood pressure 
response bo previously ineffective concentrations of norepinephrine in the 
adrenalectomized dogs, but not in the normal controls. DOCA, however, did not 
have this effect. 
In addition to the liver, the small intestine has been shown to be particular-
ly vulnerable to curtailment of blood supply in relation to its requirements for 
maintaining aerobic metabolism. Fine and his group have put forth a good deal 
of evidence for a mechanism of irreversible shock based on the increased perm-
eability of the intestinal tract to bacterial toxins when subjected to relatively 
anaerobic conditions (35). They initiated a reproducible state of irreversible 
shock by bleeding the dog into a reservior until the systolic blood pressure fell 
to 30 mm Hg. 
~The blood in the reservoir was heparinized and allowed to flow back into the 
dog, if a change in hemodynamics between the reservoir and the dog's circulatory 
volume occurred. About an hour after the bleeding had started, the dog began 
to take back some of the blood. If the dog was traasfused with what was left in 
the bottle before it had spontaneously taken back two-fifths the blood, it re-
covered in moat instances. However, if the dog was transfused after it had taken 
back more than 40% of the maximum loss, the recovery rate was reduced to less 
than 1 in 5. Generally the dog was capable of tolerating a blood pressure of 
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30 mm. Hg for an aver~ge of 4.8 hours before irreversibility developed. How-
ever, with orally administered chlo~tetracycline the dogs were able to tolerate 
this standard hypotension for much longer periods, and the recovery rate in-
creased to 88%. Experiments Wth intravenous antibiotics were of no avail, and 
neither did Clostridia antitoxin or toxoid prove to have any beneficial effects. 
Neomycin, orally·,. was as good as chlortetracycline, but oral chloramphenicol 
and bacitracin were entirely ineffective. Thus no clue was derived as to which 
bacteria were involved, but it was evident that the essential factor was the 
delivery:: of an effective antibiotic to the site of greatest bacterial action, 
namely the liver and intestinal tract, under conditions in which it could get 
there. Apparently, the duug could not get to the site of action as well if the 
antibiotic was given after shock was precipitated, when blood flow was diminish-
ed. 
These findings, according to Fine, are suggestive, first of all, of a 
rationale for theprompt treatment of shock in general. It also is appicable to 
the treatment of shock in myocardial infarction specifically. In this in$tance, 
Dr. Fine believes that a choice must be made between what is best for preserv-
ing heart function, and what is best for the ovew•ll deficiency« flow in the 
peripheral vessels. The choice in effect, is to transfuse or not to transfuse. 
With the prophylactic use of an effective antibacterial agent, it might be 
possible to postpone treating the shock during the ctitical hours of myocardial 
weakness, because the development of irreversibility may be postponed in this way. 
II. TREATMENT 
The evolution of specific therapy for shock accompanying myocardial infarct-
ion has largely paralleled the investigations of the hemodynamics and other 
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factors in the pathogenesis of this syndrome. Although at first many physicians 
regarded the hypotensive state following coronary occlusion as a protective 
mechanism, lessening the work of the injured leart (65), others observed that 
the outcome might be better if the pressure were sustained. Gilbert (44) 
advocated the prompt application of general measures to support the patient with 
a myocardial infarct, as a means of avoiding shock. Nevertheless, he was against 
the use of intravenous fluids or the peripheral vasoconstrictions available at 
the time. He stated that" •.• the blood pressure is best left where it is and 
not tinkered with." In view of the potentiality of intravenous fluids for caus-
ing pulmonary edema, and of epinephrine--like compounds for causing arrhythmias, 
his point may not have been unjustified. 
The use of active intervention in shock following myocardial infarction has 
come about only in the last 12 years (17). Methods used at first were largely 
empirical, and borrowed from the experience with hemorrhagic and traumatic shock 
in World War II. The controversy between the proponents of transfusions as 
opposed to digitalis reflects the conflict of central and peripheral mechanisms 
of pathogenesis. Both sides rested their cases on little if any experimental 
evidence, and clinical studies were difficult to control and largely inconclusive. 
In reviewing nine papers reporting a total of 650 cases with shock accom-
panying myocardial infarction, Binder found that the mortality figures tended 
to vary inversely with the reported incidence of shock (17). Thus the more 
critical the criteria for shock the worse is the condition of the patients in-
cluded, and the higher~e:mortality rate. These factors would most certainly bias 
any evaluation of proposed specific therapy. 
On one point, the consensus of all studies involving specific therapy is 
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in agreement; the sooner therapy is instituted the greater is the chance of 
success. Griffith (54) points out that many previous studies failed to dif-
ferentiate between shock cases of varying duration before the institution of 
treatment. Often cases were selected for treatment by virtue of being in-
tractable to nonspecific measures over a long period of time. The importance 
of the time factor in treatment is derived from the race against irreversibil-
ity of the shock state. Estimates of when this occurs vary considerably, but 
it has been said to occur as early as 1 hour after the onset of severe shock 
with a sysbolic blood pressure lower than 80 mm. Hg. On the other hand, it 
is questionable where one would draw the line between intractable shock and 
irreversible shock. Most estimates place the onset of irreversibility at 3-4 
hours, but cases of patients in shock for much longer periods, with recovery 
., 
upon treatment have been reported. In view of the usual delay in transporting 
patients to a hospital, methods of treatment en route must be considered, as 
well as prompt treatment with systematic rehearsed tee.work in the management 
of these emergencies (50). Gootaick has suggested that it might be prudent not 
to delay treatment until severe shock has become manifest, and that shock 
therapy be instituted in every case of myocardial infarction with a blood pres-
sure below 100 mm. Hg or a venous pressure below 25 mm. Hg (50). In this 
group a uniformly good response might be anticipated. lt must be recognized, 
howeveri that severe shock can occur in previously hypertensive patients at 100 
mm. Hg, and perhaps at higher levels (89). 
A. SUPPORTIVE THERAPY 
Although non-specific supportive therapy alone does not markedly improve 
the prognosis for patients with siges of severe shock following myocardial infarct-
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ion, it is still an important part of the management of this condition. The 
~~ 
mainstays of therapy of acute myocardial infarction•still rest, o•ygen, and 
analgesia (19). The patient in shock is deprived of adequate oxygenation of 
his tissues because of the diminished blood flow to the periphery and also 
because his diminished venous return restricts blood flow to the lungs (19). 
When pulmonary edema is present additional oxygen is regarded as a particular-
ly important part of the therapy. The early administration of oxygen has 
helped to relieve shock in some casesno~It has been suggested that the oxygen 
be bubbled through 501. ethyl alcohol at a rate of 6-8 liters per minute, and 
administered preferably via nasal catheter (87). Positive pressure should not 
be used, except in the presence of pulmonary edema, because it may interfere 
with venous return, and further depress the blood pressure. If indicated for 
pulmonary edema, positive pressure should be used only when the blood pressure 
has been elevated toward normal, and then at no more than a pressure of 10 em. 
H20, and for periods of no more than 15 minutes (87). 
Morphine has been standard therapy for acute -,ocardial infarction, and 
is indicated by the characteristic chest pain in most cases. In patients with 
myocardial infarction dominated by shock, however, pain is feequently abeent. 
Nevertheless, it is believed that analgesia is an important part of the manage-
ment of such patients. Although pain may not be evident because of a defect in 
consciousness, the pain stimulus may still serve as the afferent limb of reflex 
pathways, tending to initiate shock (96). Griffith (54) reported that morphine 
alone produced a pressor effect in severely shocked, comatose p•tients. Because 
of retarded peripheral flow, particularly through muscles (13), all analgesics 
should be given intravenously in shock (6). Morphine is given in doses of 10-
30 mg., methadone, 2-4 mg., and meperidine 50-75 mg (17), The doug should be 
dissolved in 10 cc. of sterile water and injected slowly, as all three of these 
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drugs are capable of producing hypotensive effects, but these are not usually 
marked in the recumbent position (49). However, excessive doses of these 
analgesics should be avoided for this reason. The sterile solution is injected 
into the tubing of an intravenous infusion of 57. glucose and water, which is 
started promptly on all patients in shock. Delay in starting the infusion may 
result in difficulty in finding a suitable vein, as venoconstriction increases 
as shock progresses (7). 
The patient is, of course, put at rest. The recumbent position is prefer-
red, with the foot of the bed elevated if the patient will tolerate it. When 
pulmonary edema is present, however, the head of the bed should be elevated to 
relieve orthop.,.._ia (17). "Chair treatment" for myocardial infarction is poorly 
tolerated in shock (87). Blumgart has suggested the use of elastic stockings 
from ankle to midthighS, as a simple and reasonable method of increasing the 
venous return (19). 
The prompt treatment of superimposed arrhythmias is most important tdthe 
successful management of shock in myocardial infarction. This subject is largely 
e-.c.c."pt 
beyond the scope of this paper, for a few comments particularly related to shock 
in myocardial infarction. Any arrhythmia, and particularly those of ventricular 
origin can diminish the cardiac output enough to promote or aggrevate a shock 
state. It is of great importance to distinguish ventricular from supra ventric-
ular tachycardias, as proper treatment for one may be lethal with the other (B). 
When pronestyl is used to treat ventricular tach¥cardia, care must be taken 
because of its potential hypotensive effectllf) In general, any measure which 
elevates the blood pressure of the hypotensive patient, and thereby increases 
coronary perfusion, can eliminate the ischemic focus and break the ectopic rhythm. 
Norepinephrine is particularly affective in this way, both because of its pressor 
effect and the direct effect on coronary di~ation (7). When bradycardia occurs 
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in the presence of shock, atropine may be used for its vagolytic effect to 
increase the pulse (7). Heart block, another possible consequence of myo-
cardial ischemia,, may also be relieved ay any agent which elevates the blood 
pressure and presumably increases coronary perfusion. If this fails, intra-
venous isopropylarterenol may be used to increase the ventricular rate, and 
also to potentiate the effects of norepinephrine (7). 
B. TRANSFUSION THERAPY 
The use of blood transfusions was one of the first attempted methods of 
active intervention, and was basel largely on World War II experience with shock. 
The infusion of blood or plasma into a patient with acute myocardial infarction 
brought into focus the necessity of differentiating between shock and heart 
failure, becaase it was assumed that increasing the venous retuun by enlarging 
the blood volume might be advantageous in one condition and hazardous in the 
other (107). The venous pressure was often relied upon to clarify the indicat-
ion for the use of transfusions (94). In any event, the possibility of produc-
ing cardiac decompensation by overloading the heart had to be weighed against 
the imperativeness of relieving shock with its high inherent mortality. Schwartz 
suggested that transfusion might be followed by phlebotomy if the patient emerg-
ed from shock, only t8 go intci>.taongestive failure (94). In effect, the blood 
volume would be titrated between the requirements for adequate venous filling 
and the border of decompensation. 
Epstein and Relman (32) compared the effects of transfusions in 30 patients 
who went into shock following myocardial infarction, with the course of the 
disease in twenty patients not receiving transfusion. Although transfusion 
seemed to be of benefit in a few cases, in the form of a pressor response, there 
• 
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was no significant difference between the two groups in terms of mortality and 
recovery from shock. The authors offered no conclusion as to the eff~icacy 
of the treatment, but their evidence did indicate that it was not actually 
harmful. Transfusion did not increase the incidente of pulmonary edema or 
the severity of concomitant CDngestive heart failure in this series. Actually 
the treated group had a mortality rate of 907. as compared to the mortality rate 
of 857. in the control group. However, the difference was attributed to the 
high incidence of diabetics with an initially worse prognosis in the treated 
group, whereas there were no diabeticscwmpng the controls. But most significant-
ly, the•e authors noted that cardiogenic shock can exist in the presence of an 
adequate venous return, and that the theoretical efficacy of transfusion therapy 
depends on whether the further elevation of an already high venous return can 
augment the output of a damaged heart. Others stressed the dangers of overload-
ing the heart by intravenous transfusion especially in cases in which the venous 
pressure was elevated (89). Sampson ani Singer reported 11 cases of shock after 
myocardial infarction treated with transfusion (89): only one survived, but 4 
appeared to have been carried thr .. ;he episode of acute hypotension. The prob-
lem of the narrow margin between optimu<~ and excessive venous filling was 
aggravated by the fact that rapid infusion at more than 2 ml per minute was 
required to produce a pressor effect. 
A wariation on the theme of intravenous transfusion was reported by Vogelsang 
who used the rapid infusion of iced plasma on three patients in severe shock 
thought to caused by myocardial infarction (108). Recovery occurred within 30 
seconds in each case. His hypothesized mechanism was that the cold plasma, in-
jected rapidly,either stimulated the heart directly or acted reflexly via afferent 
vagal fibers located near the S-A node near where the fluid entered the right 
atrium. Upon recovery, however, no evidence remained to attest to the myocardial 
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infarction, which the author explains on the basis of improved coronary perfus-
ion. Although the clinical validity of this report might be questioned still 
experimental verification would be interesting from the standpoint of reflex 
factors in the pathogenesis. 
After treatment had been attempted with intravenous transfusion, attent-
ion shifted to the use of intra-arterial transfusion, with the expectation of 
producing a more efficient pressor response, that is, a greater increase in 
pressure with a smaller transfusion. It was also expected tha~he introduction 
of bloop into the arterial compartment might act in a retrograde mariner to 
directly perfuse the coronary and cerebral vessels (15). Silber (100) report-
ed 9 cases with EKG evidence of myocardial infarction, clinical signs of shock, 
and systolic blood pressures less than 90 mm Hg. In 8 of the 9 cases a pressor 
response occurred within 10-20 minutes after the infusion of less than 500 cc. 
of blood. However, only two survived and these patients had the shortest 
duration of shock before transfusion of the entire group. Berman and Akman 
(15) reported another group of 8 patients who had been in shock 3-28 hours 
before transfusion of up to 1000 cc blood or plasma at 75-100 cc per minute. 
Six showed evidence of improvement and one survived. These authors emphasized 
that the theoretical value of intra-arterial transfusion depended largely upon 
how soon after the onset of shock the transiasion was administered. Thus, early 
in shock state, when peripheral vasoconstriction is maximal and arterial outflow 
retarded, the retrograde effect of the intra-arterial infusion would be more 
effective. However~, it has been pointed out that the phase of compensatory 
vasoconstriction occuring in shock serves mainly to channel blood more direct-
ly from arterial to venous side via metarterio~· (59). 
~ 
·· .. ,. 
The instances of success with the early use of intra-arterial infusion is 
probably more attributable to the generally improved prognosis known to exist 
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when treatment is instituted early, in the course of shock, than to the treat-
~ ment~ The theoretical advantages of intra-arterial infusion were almost 
entirely contradicted when a controlled comparison of the effects of intra-
arterial versus intravenous transfusions was made. Maloney (68) concluded 
the expected hydraulic effect of the intra-arterial transfusion was insign-
ificant at rates of infusion used clinically, that the recovery of arterial 
pressure is a function of the rate, rather than the route of transfusionJand 
that their effectiveness is restoring cardiac output are about equal. Further-
more, changes 6n venous pressure and occurance of heart failure were not 
related to the route of infusion. Howewer, these s~udies were all done in 
hemorrhagic shock, and not all the results aan be extrapolated to the treat.ent 
of cardiogenic shock without reservation. Direct perfusion of the cornnary 
arteries by intra-arterial infused blood was shown by radiographic techniques 
to occur only when the output of the left ventricle is negligable or non-exist-
ent. Direct perfusinn of cereb•al arteries with unsaturated blood given 
intra-arterially was shown to decrease rather than increase cerebral arterial 
and venous oxygen saturation. At any rate, by 1954, Blumgart was convinced 
that intra-arterial transfusion demonstrated no real superiority to intra-venous 
transfusion in the treatment of shock due to myocardial infarcti6n. 
C. DIGITALIS 
Digitalis has been widely regarded as contraindicated in shock ·following 
acute myocardial infarction. Goodman and Gilman state that unless congestive 
failure is present, digitalis is contraindicated (49). When shock is present 
however, they believe that ~igitalis may further decrease cardiac output, increase 
the chances of ventricular tachycardia or fibrillation originating from the 
ischemic focus, or undesirably strain Ohe myocBrdium. Those who would agree 
with Boyer, however, that shock and congestive failure following myocardial 
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infarction are the aame condition, would a"gue that in spite of any real or 
apparent hazards to the use of digitalis, it is nevertheless the therapy 
of choice for shock following acute myocardial infarction. Boyer maintained 
this in 1944 (20), and reiterated it in 1955 (21) when he reported a group 
of 50 patients with myocardial infarction including some wlth shock, congestive 
failure, and atrial fibrillation, with a 16% mortality for the group as a 
whole. There were no controls and the report was not meant to be conclusive 
..... 
except to show that the ea.e of digitalis is not as dangerous as previously 
thought. Gorlin and Robin (51) reported 4 cases in shock following myocardial 
whi.h 
infarction~responded to cardiac glycosides when other methods including vaso-
pressors failed. As a rationale, they suggested that the diminished cardiac 
output plays en important role in cardiogenic shock, regardless of the state 
of total peripheral resistance. Furthermore, the defect in cardiac output is 
regarded as not merely one of diminished venous filling, because restoration 
of venous pressure alone has proven of little help in relieving cardiogenic 
shoak. They consider vasopressors to be the first line of defense, with the 
objective of increasing total peripheral resistance and decreasing the vascular 
volume to be perfused. The second line, however, is to increase the stroke 
volume of the heart and maintain perfusion pressure by digitalization. 
Because these men were writing at a time when vasopressors were being 
used with inccreasing effectiveness in the management of this condition, it 
is understandable that they would regard vasopressors as the first line of def-
ense. It is not quite consistent with their strong assertion th•t shock follo~ 
ing myocardial infarction is a manifestat6on of forward failure alone even when 
overt evidence of failure is absent, as it frequently is. However~. they do make 
the point that cardiac glycosides may contribute significantly in maintaining 
blood pressure by supporting the cardiac output, and as others have contended, 
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without as much hazard as was previously supposed. (9,21). 
When signs of frank congestive failure are added to those of shock in 
myocardial infarction, digitalization is unquestionably indicated (17). Under 
these circumstances, digitalis is best given in divided doses, with an EKG 
strip taken before each dose in order to detect early evidence of toxicity. 
Oubain provides a means of rapid digitalization, starting, with 0.5 mg. 
intravenously, followed by 0.1 mg. every hour until approximately 0.8 mg. is 
given. Lanatoeide C may be used if less rapid digitalization is desired, start-
ing with 0.8 ~· intraveously, followed by 0.4 mg. at 2 hour intervals. The 
average digitalizing dose is 1.6 mg.(l7). 
D, VASOPRESSORS 
The first real dent in the mortality figures regarding shock in acute myo-
cardial infarction has been made within the last ten years with the development 
of effective vasopressor drugs. When standardized criteria are applied to 
reported cases with non-specific therapy alone, the mortality is seen to vary be-
tween 80-90%. Transfusions have brought about no significant difference (17). 
The use of Vasopressor therapy has increased the salvage rate by 20-301, with a 
mortality of 60-701. in comparable groups of patients (7). In comparison to 
specific therapy which has arisen for the treatment of other medical conditions, 
this improvement is not startling. However, the condition in question is a 
complication of an underlying disease state having many other hazardous, potent-
ial complications, and a significant over-all mortality. The fact that any therapy 
can be effective supports the experimental and clinical observations that the 
incidence of shock does not necessarily correlate with the extent of the infarct, 
~ or qullity and quantity of the remaining myocardium (74). It also supports 
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the statistical evidence that shock does not occur predominantly in the oldest 
age group of patients (116). In short, it indicates that we are dealing with 
something more than failure of a debilitated myocardium, and that a peripheral 
mechanism is implicated in addition to an undisputed cdntral component. 
The extensive use of vasopressor drugs in cardiogenic shock came about 
with the introduction of norepinephrine as a clinically useful pressor agent. 
Acbaally, the drug itself has been known for a considerable time. It was 
synthesized as early as 1904, and its pressor activity and lower toxicity in 
comparison with epinephrine were recognized at that time (34). However, its 
biological importance was not recognized until 1946, when it was shown to be 
the neurotransmitter of adrenergic nerves (33). Probably the first clinical 
trial of norepinephrine as a pressor drug came in 1949, when it was used to 
aaintain blood pressure during thoracolumbar sympathectomy (47). Favorable 
reports of its effectiveness in circulatory collapse following myocardial in-
farction appeared in the European literature in 1950 and 1951, and in the 
English literature in 1952 (33). Miller and Baker (74) treated 7 patients, all 
of whom had had a systolic blood pressure less than 8Cmm. Hg. for at least four 
hours with intravenous norepinephrine (~g.per liter). F~out of 7 had a sig-
nificant pressor responseJbut only one survived. However, in the three patients 
that had the pressor response and subsequently died, the infusion had been 
stopped abruptly. Their experience suggested that the norepinephrine infusion 
should be tapered off instead of being stopped short when the blood pressure 
has been maintained. Kurland and Malach (64) reported more favorable results 
with 14 patients with shock following myocardial infarction as determined by 
the clinical picture and blood pressure less than 90 mm. Hg, all but one being 
less than 80 mm. Hg. Two-thirds of the patients exhibited a significant pressor 
response, and 4 ultimately survived. In these cases, and in shock due to other 
I 
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causes, an effective pressor response occurred in patients who had previously 
failed to respond to oxygen, shock blocks, plasma and blood infusions, paredrine 
phenylephrine, and epinephrine. The use of norepinephrine did not appear to 
seriously aggravate pulmonary edema, nor were any arrhythmias attributed to its 
use. Complications were chiefly localized to the site of infusion, with 
venospasm, pallor, cyanosis, red streak:)rt:' phlebitis> vesicular eruption, and 
ulcerations. Severe local complication occurred mostly when some of the in-
fusion extravasated into the tissues, but in one case a deep ulcer occurred 
without extravasation. 
The rationale for the use of norepinephrine in shock following myocardial 
infarctions was made somewhat un~raain by early studies comparing its central 
and peripheral effects. The initial hemodynamic studies indicated that cardiac 
output was unchanged or devreased during norepinephrine infusion and that the 
rise in blood pressure was entirely caused by a marked increase in total peri-
pheral resistance (12,46). Any favorable effect on the myocardium was thought 
to be caused by the secondary increase in coronary flow following the rise in 
blood pressure. (74). It was soon demonstrated, however, that coronary dilit-
ation is a specific pharmacologic action of norepinephrine, and that it exceeds 
epinephrine in this respect (101). Furthermore, increased saturation of coronary 
sinus blood following norepinephrine infusion suggests that coronary blood flow 
is increased to a greater extent than is demanded by the increased utilization 
of oxygen with the daug (61). When the contractile foree of the heart itself 
was measured following norepinephrine admhistration, it was found to be increas-
ed in all cases (43,48). It was therefore concluded that measurements of 
norepinephrine effects under normotensive conditions can be misleading because 
it raises the blood pressure from normal to hypertensive levels by increasing 
resistance, thereby depressing cardiac output, as in essential hypertension. 
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When norepinephrine is used in hypotensive states, however, the resistance to 
cardiac output is raised to normal or slightly subnormal levels, and here the 
effect of the drug on myocardial contractility has a significant beneficial 
effect on cardiac output. The greater effectiveiess of norepinephrine in the 
management of sh.ck due to myocardial infarction in comparison wLth other 
,~~.,ts 
pressor drugs having lesser heart contractile forceA(41,91) suggests that the 
assumption>made from the hemodynamic effects are correct. 
A similar difference has been observed relating to the tendency of nore-
pinephrine to produce aardiac irregularities when used to raise the blood 
pressure from normal ::to hypertensive levels, as opposed to supporting a normal 
pressure in the treatment of shock (76,93). Although some early reports ind-
iaated (42,53) that an arrhythmogenic effect might be a hazard in the treatment 
of cardiogenic shock, wide clinical application has largely dispelled this fear. 
When ectopic rhythms do occur they more often originate from auricular foci than 
ventricular foci (76). Rare instances of ventricular tachycardia attributed to 
the use of norepinephrine in the treatment of shock due to myocardial infarct-
ion have been associated with use of excessive dosages (90). The favorable 
effect of norepinephrine on the oxygen tension in localized ischemic areas of 
the myocardium may work to prevent the developaant of arrhythmias. Norepinephrine 
was shown to produce greater and more rapid improvement of oxygenation in the 
ischemic area than the inhalation of pure oxygen alone, but together their effects 
are synergistic (93). Furthermore, improvement of the oxygenation of the ischemic 
myocardium, along with improvement of coronary blood flow, c6istitute an attack 
on the basic etiologic factors in shock due to myocardial infarction regardless 
of whether one accepts a central or peripheral mechanism for the shock state.(l04). 
Studies on the effects of norepinephrine on renal hemodynamics showed that 
a decrease in renal blood flow and glomerular filtration rate accompanied thet 
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pattern of vasoconstriction consequent to its infusion into normal subject (77). 
This was regarded as a possible contraindication to its use in shock states, 
in which renal function had been found to be depeessed by the same mechanism. 
Subsequent studies, however, revealed that renal function is improved when 
norepinephrine is infused in shocked dogs (76), snd experience has born out 
this observation in clinical shock (17). This effect is attributed to the 
increase in filtration fraction consequent m the pattern of renal vasoconstrict-
ion in response to norepinephrine infusion (81). Thus, improvement in urine 
flow is recognized as an important sign of s favorable response when norepine-
phrine is used in the treatment of shock of myocardial origin (7). 
Subsequently appearing papers in the literature reported extremely variable 
results with the use of norepinephrine in shock due to myocardial infarction. 
Usually the treated group in the reported series is quite smsll, and only an 
impression of effectiveness rather than a statistical conclusion can be de-
rived. Papers reporting a survival rate of 1 out of 6 (66) can be contrasted 
with others published roughk1 at the same time with a survival of 6 out 
patients (43). The few reports based on slightly larger series (17,90) 
of 7 
are far 
more consistent most often reporting a 30-35~ rate of survival with adequate 
treatment. Several factors have been put forth to explain the variability of 
the response to therapy with norepinephrine. Some authors have observed a 
difference in responsiveness in cases• in which shock is an early manifestation 
of myocardial infarction as opposed to shock wbich appears several hours to 
days after the onset of the infarct. (90,96). DelJyed onset of shock is re-
garded as a manifestation of extension of the infarct with progressive failure 
of the infarcted ventricle (90). Shock developing immediately,.ffon the other 
'i 
&and, may represent a derangement of circulatory homeostasis and the outlook 
with adequate treatment ia much more favorable. According to Sampson and 
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Zipser, recovery can be expected in SOt of the cases of immediate shoca with 
treatment, and often spontaneously. They regard the delayed type, however, 
as almost invariably fatal. Sigler (99), however, reports a case in which 
shock developed late in the course, accompanied by pulmonary edema and neck vein 
distention, which was followed by recovery after 21 days of vasopressor ther-
apy. Others have observed that a greater proportion of fatalities occur in 
second or later attacks of myocardial infarc~ion, and conclude that an ade-
quate myocardial reserve is essential to successful treatment (76). 
An important conclusion about the role of shock in myocardial infarction 
can be deduced from these and previously mentioned obwervations. The over-all 
mortality from myocardial infarction is increased with the occurance of shock, 
but the incidence of shock does not depend on myocardial reservepo~.However, 
the~~ mortality, once shock has occurred, does depend a great deal on the 
residual functional capacity of the myocardium. 
The duration of shock before therapy is instit~ed has an important bearing 
on the success of treatment because of its cr*cial relationship to the develop-
ment of irreversibility. Ga~s treated seven patients with systolic pressures 
less than 80 mm. Hg for 1-1~ hours before treatment with norepinephrine, and 
six recovered (43). The one remarkable exception, however, was one patient 
who had been in shock for 12 hours and recovered with treatment. In another 
ser~es, the duration of shock before treatment average. 1 hour and 40 minutes 
among survivors, and 5 hours among fatalities (41). Among patients treated 
soon after the onset of shock, it makes little difference in the prognosis whether 
the blood pressure is unobtainable, or ranges between 40 and 80 systolic lt7~ 
Others aspects of treatment with norepinephrine that have been found to be 
of prognostic significance in shock following myocardial infarction '"* the 
dose ~'quiral to elevate the blood pressure initially (90)land the amount of 
-37-
norepinephrine per unit time required to maintain the blood pressure (16). The 
· Col) duration of treatment before the pressure can be maintained independently, and 
the total dose admin~ered, however, were found not to have prognostic signef-
~~-J et y., " icance (16,90). Although tachyptaete:i'- has been demonstrated experimentally 
in the cat, (28a), a progressive refractoriness to increasing concentrations 
of norepinephrine in man is seen only in instances of irreversible shock which 
have been maintained,, on pressor agents for long periods of time. (76). Others 
have assumed that irreversibility might be overcome if blood flow to vital organs 
were maintained long enough with pressor agents (66). However, experience has 
proven that the poor prognosis when treatment has been delayed is unchanged by 
the length of time the pressure is supported by vasopressor agents (7,3). Fail-
ure of a pressor response is, of course, of ominous significance (64). 
As previously mentioned under the administaation of analgesics, a needle 
should be inserted into a vein immediately and attached to a 5% glucose and 
water infusion, because veins become increasingly hard to locate as shock prog-
resses. If severe shock is present or impending, norepinephrine should be 
added to the infusion immediately. The contents of 1-3 ampules containing 4 mrm 
is 
of norepinephrine"added to the liter of glucose and water (7). The rate of 
infusion is then ~ftrated with the blood pressure. A level of 100 m8· Hg is 
usually desirable except in previously hypertensive patients in whom a some-
what higher level of blood pressure must be maintained to relieve the symptoms 
of shock (19). The blood pressure should be checked feequently as it is being 
titrated, for an overshoot in blood pressure may be detrimental to the injured 
myocardium. If a marked overshoot occurs it can be corrected by the adminis-
tration of amyl nitrate, (7), but this, too, has its inherent dangers (19). 
The rate of infusion should not exceed 1.5 cc or 30 drops per minute and because 
the patient may be easily overloaded with fluid; lee per jinute or less is 
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preferable(6r'sther than further increase the rate of infusion, the concentration 
of norepinephrine should be increased until an adequate pressor response is ob-
tained. Estimates of the maximum concentration beyond which further ;ncrements 
may be futile have varied between 16 and 60 mgm per liter (88,107). As soon 
" as possible after the desired blood presure is achieved, a catheter should be 
inserted and the rate of urine flow determined (7). This is the most sensitive 
indicator of the progress of the patient. Unless a flow of urine of ~ cc per 
minute is achieved, the patient must be resarded as still in shock, although the 
blood pressure may be greater than 100 mm Hg. This is particularly important 
in previously hypertensive patients. While the infusion is PUnning, the rate of 
flow, concentration of the drug, blood ~ressure, pulse, and respirations must 
be monitored every 1/4 to 1/2 hour (88). When the patient appears stabilized, 
the rate of infusion should be decreased gradually as stopping the infusion 
suddenly is likely to cause a precjpitous drop in blood pressure (6). Even if 
pressure is maintaned after tapering off the norepinephrine infusion, the 
intravenous set-up should be left in place for 12·24 hours so that it may be 
resumed immediately in an emergency (19). Notinfrequently, the pressure may 
have to be maintained for six days or more vefore it is indepiadently stabil· 
ized. 
When prolonged administsation is indicated, a polyethylene catheter may 
be threaded into an arm or leg vein to avoid leakage of the infusion ento the 
surrounding tissues where it will cause a slough (7). Other precautions for 
preventing extravascular necrosis include the use of warm packs at or above the 
level of the meedle, and the avoidance of using veins in the hand or foot (19}. 
Particular caution is required with patients having diabetes or other peripheral 
vascular disease. The production of sevdre sloughs at the infusion site is so 
I 
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serious a hazard, that the use of norepinephrine as the agent of choice has 
been questioned on this basis (95). Even without extravasation, tissue ischemia 
has been shown to occur over the course of the infusion veins (24). Severe 
tissue necrosis usually follows extravasation, however. When extravasation is 
known to have occurred, necrosis can be prevented by local infiltration of the 
area with adrenergic blocking agents such as phentolamine and tolazoline (24,70, 
118). A dose of 5 mgm of phentolamine in 20 cc of sterile water has been suggest-
ed. SJough has been prevented up to si& hours after the extravasation of 
norepinephrine into the rabbit skin, but not after 24 hours. Hyaluronidase has 
been injected along with the adrenergic blocker, but its contribution is question-
able. 
Other Pressor Agents 
Other pressor drugs that have been used for shock following myocardial in-
farction are metaraminol (Aramine), phenylephrine, (Neosynephrine~ Tilethoxamine 
(Vasoxyl)
1 
and mephenteramine (Wyamine). Some of their cardiovascular actions, 
doses, and routes of administration along with those of norepinephrine are compared 
in table II. Norepinephrine is still regarded as the most potent pressor agent 
in coronary shock, but the chief advantage of the others is greater ease of 
administration. All of these pressor drugs except norepinephrine may be given 
intramuscularly and have a longer duration of action, making a continuous intra-
venous infusion unnecessary. Norepinephrine, on the other hand, offers the 
advantage of greater moment to mement control over the course of the blood press-
ure. The rdative effectiveness of each of these agents inshock following myo-
cardial infarction has been shown to be clearly correlated with their effects on 
the contractile force of the heart. Gol~berg et al (48), compared the effects 
of 15 available sympathomimetic amines in equipressor doses with an ''' Adrenaline 
Standard," which increased the contractile force of the heart in the vagotomized 
TABLE II. VASOPRESSOR DRtJ;S * 
NAME INOTROPIC PULSE CORONARY I ROUTE DOSE C<Jo!MENI' 
Neosynephrine None lows ~one ~ubc, -10 mg Useful in parox-
(Phenylephrine 1 I ysmal tachycard-
I ia. 
II.M. ~-10 ~ Not used in part• ' 
' ~5m!gq/~~c~~n) ial heart block. I ji.V. I ' f 
I None Slows lfone j' ; Vasoxyl li.M. k0-15 mg. Useful in parox-I (q 15 min.) ysmal tachycard-Cen. Ven, I 
Pr. {. illl. v. no mg ia; no tachy-
'Infusion 112.0 mg/100 cc, phylaxis, 
i 
Wyamine Positive ~one ~ncreased I.M. 115-35 mg Possible tachy-
(Mephentermine) !(15 min delay) ph!Jlaxis. 
I.V. 5-20 mg 
Infusion 11 mg/min 
I ' 
Levophed I May ! ! (Levarterenol) !Positive slow Increased j ug/min May cause slough Infusion l4·8 ! 
' Aramine i ' ! (Metaraminol) !Positive None Increased Subc, p-10 mg No slough; no 
I I.M. 12-10 mg tachyflhylaxis; 
I.v. 3.0-20.0 mg/ prolonged action, 
100 cc 
L--· 
-
---·-
Subc, - Subcutaneous 
I.M. - Intramuscular 
I.V. - Intravenous 
Cen. ven. pr. - central venous pressure, 
* Agress, C.M. Management of Coronary Shock. A.M.J. Card. 1:231, 1958 
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dog by 140% over control values. Epinephr6ne and norepinephrine were found to 
have contractile force effects about equal to the standard. The other drugs 
tested fell into two groups. One, which included phenylephrine and methoxamine, 
was characterized by contractile force effects ranging between 30-40% of the 
standard. The second group, which included, mephenteramine also approximated 
the standard in contractile force effects. Metaraminol was not available at 
the time, but it has since been shown to have a positive inotropic effect of the 
same magnitude as norepinephrine and mephent~eramine (92). 
Following the aecognition of this difference between the available pressor 
drugs, other studies (43,91) revealed that drugs which increase the contractile 
force of the heart tend to be more effective in shock of myocardial origin than 
drugs which merely increase peripheral resistance. These sbbdies show¥ed that 
this is the result of a direct inotropic effect, rather than the effect of only 
an increaed coronary perfusion as was previously believed (92). Arguing back-
wards to the pathogenesis, this is strong evidence for the central componenet in 
this disorder. However, the primary importance of the peripheral pressor effects 
of these drugs is emphasized by their superiority over digitalis alone. 
Phenylephrine has been in clinical use as a pressor agent longer than nore-
pinephrine, but little success has attended its use in shock accompanying 
myocardial infarction. For this reasion, interest in vasopressor agents for this 
purpose evolved only with the appearance of norepinephrine clinically, and at 
this time there was some reevaluation of phenylephrine (25). Clinical exper-
ience with phenylephrine in shock due to myocardial infarctions reveals that 
although a pressor response is usually obtained, the blood pressure rarely 
becomea stabilized and the mortality is not improved (41). The pressor response 
~ is characterized by narrowing of the pulse pressure, whereas norepinephrine 
tends to widen the puke pressure (41). There is (80) some evidence of tachyphy-
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laxis with continued use of phenylephrine. 
Methoxamine has been suggested as a suitable pressor drug for use in 
shock accompanying myocardial infarction chiefly because of its safety with 
respect to cardiac arrhythmias, even after cyclopropane sensitization (79). Both 
clinically (16) and experimentally (91), methoxamine has been found wanting 
when used for this purpose. Although it increases peripheral arterial pressure 
left atrial pressure tends to be markedly increased indicating an over~oading 
effect on the heart. The N.N.R. (8), accepts jts use in cardiogenic shock only 
with reservations based on its lack of a cardiotonic effect. In addition to its 
lack of a positive inotropic effect, .. thoxamine lacks the specific coronary 
dilating effect of norepinephrine (61). Methoxamine produces an increase in 
coronary flow Wich is only proportional to the increase in systemic pressure. 
The pressor response is therefore not as benefidal to the ischemic myocardium as 
is that of norepinephrine. 
Favorable results have been reported in shock following myocardial infarct-
ion using mephenteramine (22,56). Although it was at first thought to affect 
only peripheral vascular resistance, subsequent studies revealed a positive ino-
tropic effect, which is regarded as an important factor in its effectiveness in 
(Ill) 
shock of myocardial origin~ It is characterized by a prolonged duration of 
action; pressor effects last 30-50 minutes after intravenous injection and up to 
4 hours intramuscularly (49). It has been suggested as a less troublesome 
method of treatment for milder hypotensive states following myocardial infarction 
(41). 
Metaraminol is the most recently developed, and next to norepinephrine, the 
most •otent of these agents shock following myocardial infarction. Like 
mephenteramine its duration of action is prolonged by all routes of administration 
and is innocuous with regard to cardiac arrhythmias even in the presence of 
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myocardial hypoxia. Its hemodynamic effects were studied in great detail by 
Sarnoff et al (92), with specific reference to its action in coronary shock. 
In the vagotomized dog it was found to increase aortic and pulmonary pressure, 
cardiac output and coronary flow, and to decrease right and left atrial press-
ures. When heart failure was present, the decrease in atrial pressure. was 
greater. By differentiating between systemic and cardiac effects by time 
dissociation techniques, it was found that metaraminol increases peripheral 
resistance markedly, producing an increased aortic pressure and a slightly 
decreased cardiac eutput. Coronary flow is also increased. The direct effect 
of the drugs on the myocardium, however, produces a marked increase in cardiac 
output and a further increase in coronary flow. Whereas the s~stemic effect 
tended to increase left atrial pressure, a much greater decrease was produced 
by the direct cardiac effect. Thus with an increase in cardiac work at a decrees-
ed filling pressure the heart may be assumed to be operating en a more favorable 
Starling function curve. 
Subsequent clinical studies revealed that on a weight basis, metaraminol 
is less potent than norepinephrine when administered by constant intravenous 
infusions (77a) but that blood pressure was easier to maintain at a constant 
level, however, and fewer blood pressure determination were required. Dislodg-
ing of the needle, which has been regarded as an inevitable occurance in extend-
ed intravenous therapy, is not accompanied by a sudden fall in blood pressure 
as with norepinephrine 1106). No tachyphy1axi$ was observed (110). The use of 
the drug has been accompanied by few side effects, and no slough occurs when 
the fluid is extravasated into the skin (77a). Bradycardia commonly occurs when 
the drug is adminstered to normotensive patients, but is rarely seen in hypo-
tensive patients (109). Atropine blocks this reflex bradycardia. Norepinephrine 
has been effective in producing a pressor response in certain Q8ses which failed 
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to respond to metaraminol, but ultimate survival was not markedly improved in 
these instances (110). 
In many ways, metaraminol approaches the ideal pressor agent, except that 
it is somewhat less potent than aorepinephrine. Because it can be given sub-
cutaneously or intramuscularly, it is an excellent drug to be used on an 
... egency basis in which the patient is being transported to the hospital, or in 
other circumstances where intravenous therapy is impBattical. It has also 
been suggested that after the blood pressure has been stabilized on an intra-
venous infusion, it may be maintained by intermittent injections of metaraminol 
(106). The advisability of this would probably depend on the severity of the 
case, as it might be hazardous in severe cases in which instantaneous control 
of the blood pressure would be desirable. 
E. THORACIC EPIDURAL ANALGESIA 
Agress and his group (7) have used thoracic epidural analgesia to potent-
iate the effects of norepinephrine in patients with severe coronary shock who 
failed to respond to all other measures. This approach was based on their 
evidence thaa:innsbme paU.ents coronary shock ia due to failure of the total 
peripheral resistance to rise in the face of a falling cardiac output, and 
that this may be caused by an inhibitory reflex originating in the injured myo-
cardium. Hemodynamic measurements in dogs, with experimental coronary shock 
indicated that cutting the posterior foots of Tl-TS produced a prompt rise in 
total peripheral resistance, with no change in cardiac output. Furthermore, 
after thoracic epidural analgesia, a smaller amount of norepinephrine produced 
a much greater rise in both blood pressure and total peripheral resistance. 
This method has been applied to a few patients who failed to respond to all other 
known aeasures, with limited success. Figure II, illustrates a case in which 
a patient in severe coronary shock whose blood pressure had failed to stabilize 
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* Agress, c.M. Management of coronary shock, Am. J. Card. 1:231, 1958 
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Qlld 
despite larger doses of norepinephrine, as well as oubain~hydrocortisone, was 
treated with procaine injected into the thoracic epidural space. Patients have 
generally not responded when several hours have elapsed since the onset of shock 
or when congestive heart failure has been superimposed. Further studies with 
this method are in progress at the present time. Because the patients on whom 
it has been tried have been unresponsive to treatment with vasopressors, and there-
fore fall into group with an expected mortality of 100%, thoracic epidural an-
algesia may make a small but significant dent in the unfavorable prognosis in 
coronary shock. 
F. APPROACHES TO IRREVERSIBLE SHOCK 
Most of the failures of therapy in shock following myocardial infarction, 
however, can be attributed to the development of irreversibility. In many 
instances, the delay between the onset of shock and the institution of treatment 
is beyond medical control. Once the case is discovered, immediate injection of 
a vasopressor agent and maximal efficiency is instituting intravenous therapy 
have been recommended as measures which may specifically improve the salvage 
rate somewhat. Measures specifically aimed at preventing or altering the state 
or irreversibility have met with little success but deserve theoretical consider-
ation. 
Based on demonstrated relationship between adrenal stereids and vascular 
m.) 
reactivity, attempts have been made to potentiate the response to norepinephrine 
in coronary shock with cortisone and ACTH. Kurland and Freedberg (63) report-
ed that such potentiation occurred clinically, but this treatment has been large-
ly disappointing in shock accompanying myocardial infarction (7,87). 
The use of anticoagulants to prevent irreversible shock has been suggest-
ed on the rationale that hyperactivity of the blood coagulability contr'l 
mechanism is a possible cause of irreversible shock. Decreased coagulation time 
has been demonstrated in dogs bled until a state of irreversible shock has 
been reached (28). The appearance of multiple small thrombi in the coronary 
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arteries of patients dying of shock lends further support to this concept (18). 
Furthermore, Wright, Matple, and Beck found a significant difference in the 
mortality rate among patients with shock following myocardial infarction receiv-
ing anticoagulant therapy and those not receiving it (116). In view of the 
controversial aspects of this subject, the problem of irreversible shock might 
be another serious argument in favor of the use of anticoagulants • 
The evidence for the role of •nteric bacterial toxtdns in irreversible 
shock naturally suggests the use of prophylactic antibiotics in this and other 
. {;\S,S).) 
forms of shock. Dr. Fine's experimental results'showed that prp~~ylactic anti-
biotics are effective only if administered before the production of the shock 
state; the essential factor is the delivery of an effective concentration of drug 
to the liver and intestine (35). 
Others have demonstrated a protective e~fect against irreversible shock 
of adrenergic blocking agents (11,59). This technique has been used mostly 
in relation to shock incident to anaesthesia (59). It was thought that these 
agents acted against the compensatory initial vasoconstriction in shock$, and 
allowed unrestricted peripheral blood flow which would maintain adequate 
oxygenation and nutrition of the tissues and thereby avert the metabolic derange-
ments leading to irre~rsible shock. The requirements of the increaaed circulatory 
volume consequent to the use of these drugs was made up by transfusion, so that 
venous return and tissue blood flow were both adequate (117). Careful evaluation 
of several autonomic blocking agents, however, revealed that the protective effect 
did not reside in any parti·cular pharmacologic ,property of these drugs (59). 
Certain blocking agents, including adrenergic, cholinergic, and ganglionic Hock-
ers, were found to have a protective effect, whereas other drugs of the. same 
pharmacologic types had no effedt. The protective effect was therefore thought 
to reside in actions of the drugs on the cellular level, unrelated to their 
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autonomic effects. One possible mechanism of action is suggested by the fact that 
ferritin or VDM is known to contain biologically active sulfhydryl groups, and 
dibe~line and atropine, which were two of the protective drugs have been shown 
to have sulfhydryl binding properties at the cellular level. 
The common fault in all of these theoretical aaawers to the problem of 
irreversible shock is that they require pretreatment before the state of irrevers-
ibility develops. On the other hand, maintenance of the blood pressure with 
pressor agents also provides this protection, no matter how long the pressure 
need be supported, provided the treatment is instituted soon enough. The patient 
who presents with severe shock of several hours duration is in most cases refract-
ory to any of these measures. The factors which are involved in the decompensat-
ion of the peripheral vasculature at pfesent appear too numerous to permit a sin-
gle soiution. Before treatment can begin, a better understanding of the cell-
ular mechanisms must be achieved. 
III. CONCLUSIONS 
There is now a good deal of evidence indicating that shock following acute 
myocardial infarction is a distinct entity, separate from other forms of shock 
and from congestive heart failure. tt is different from heart failure in that 
both central and peripheral defects in vascular homeostasis are involved. It 
is different from other forms of shock because the central defect is the initiat-
ing factor, and is not secondary to decreased venous return. However, each of 
these factors interacts upon the other, producing a viJ'cious cycle. In spite of 
compensatory mechanisms, the body as a whole suffers from the diminution of blood 
flow, adding •ew factors to the cycle, all leading to a state of irreversibility 
in which the capacity to sustain life is lost. 
The aentral defect in cardiac output is a constant feature of myocardial 
infarction, and is usually severe when shock is present, but may be equally severe 
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in its absence. The extensiveaess of the area of myocardial injury does not 
necessarily correlate with the occurance of shock. In some cases of shock 
of myocardial origin thetotal peripheral resistance fails to rise as the cardiac 
output falls. Strongly suggestive evidence has been presented for the feflex 
inhibition of compensatory mechanisms in these cases. In other cases the peri-
phehal resistance rises normally, but is not adeguate to compensate for the 
fall in cardiac output. Here the injury to the myocardium must be assumed to 
be extensive, and the central component is .. primarily at fault. Because of 
the interaction of central and peripheral factors, however, it is usually im-
possible to differentiate one type of circulatory failure from the other. 
The role of both central and peripheral components in shock of myocardial 
origin is reflected in the efficacy of treatment by vasopressor agents which 
affect both the heart and the peripheral vasculature. The use of these agents 
has reduced the mortality rate from 80 per cent to eae of 60 per cent. Methods 
of treatment directed toward either mechaniam alone, such as transfusions, card-
iac stimulants, and certain vasopressor agents, have not altered the mortality 
rate. If the fault is not that of an overwhelming insult to the myocardium, 
a favorable result may be expected only if definj~ive therapy is instituted 
rapidly enough to head off the development of irreversi.ility. Hope for further 
improvement in the prognosis rests with more direct methods if interrupting ref-
lex mechanisms contributing to the initiation of shock, and further understanding 
of the nature of irreversible shock. Nevertheless, shock following acute myocard-
ial infarction remains a difficult and often frustrating clinical problem. 
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